Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis

BMC Systems Biology

Long Cui¹  Jun Gao²  Yunxiang Zhu³  Jingming Li¹  Wei Chen¹  Guanghui Wang¹  Peng Du¹  Wentao Tang³  Jihong Fu¹ 

[1] Colorectal Surgery Department, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Kongjiang Road 1665, Shanghai, 200092, China;Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Changhai Road 168, Shanghai, 200433, China;Second Affiliated Hospital, Yangzhou University, Jiangsu, 225001, China

关键词: Microarray;    Colorectal cancer;    Target mRNAs;    MicroRNAs;   

Others  :  1144185
DOI  :  10.1186/1752-0509-6-68

 received in 2011-10-28, accepted in 2012-06-15,  发布年份 2012

【 授权许可】

   
2012 Fu et al.; licensee BioMed Central Ltd

【 参考文献 】

• [1]Gregory RI, Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 2005, 65(9):3509-3512.
• [2]Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4):259-269.
• [3]Schee K, Fodstad O, Flatmark K: MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 2010, 177(4):1592-1599.
• [4]Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, Kornmann M: Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2006, 2:113-121.
• [5]Slaby O, Svoboda M, Michalek J, Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009, 8:102. BioMed Central Full Text
• [6]Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Sinar DR, Naziri W, Marcuard SP: Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 2009, 6(5):281-295.
• [7]Faber C, Kirchner T, Hlubek F: The impact of microRNAs on colorectal cancer. Virchows Arch 2009, 454(4):359-367.
• [8]Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127(1):118-126.
• [9]Li JM, Zhao RH, Li ST, Xie CX, Jiang HH, Ding WJ, Du P, Chen W, Yang M, Cui L: Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Med J 2012, 33(1):24-29.
• [10]Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009, 34(4):1069-1075.
• [11]Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 2010, 11(1):50-54.
• [12]Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundstrom J, Ristamaki R, Osterlund P, Knuutila S: MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 2012, 51(1):1-9.
• [13]Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, et al.: Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28(10):1385-1392.
• [14]Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, et al.: Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 2008, 18(8):823-833.
• [15]Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58(10):1375-1381.
• [16]Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X, Du X: MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 2011, 71(7):2582-2589.
• [17]Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, et al.: MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol 2011, 37(7):597-603.
• [18]Sun K, Wang W, Zeng JJ, Wu CT, Lei ST, Li GX: MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin 2011, 32(3):375-384.
• [19]Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Kang T, Huang W: MicroRNA-342 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Directly Targeting DNA Methyltransferase 1. Carcinogenesis 2011, 7:1033-42.
• [20]Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20.
• [21]Maziere P, Enright AJ: Prediction of microRNA targets. Drug Discov Today 2007, 12(11–12):452-458.
• [22]John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS: Human MicroRNA targets. PLoS Biol 2004, 2(11):e363.
• [23]Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microRNA.org resource: targets and expression. Nucleic Acids 2008, 36:149-153.
• [24]Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
• [25]Cannell IG, Kong YW, Bushell M: How do microRNAs regulate gene expression? Biochem Soc Trans 2008, 36(Pt 6):1224-1231.
• [26]Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, Aicher LD, Proll S, Katze MG: Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 2009, 10:373. BioMed Central Full Text
• [27]Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, et al.: Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 2010, 4:51. BioMed Central Full Text
• [28]Lopez-Romero P, Gonzalez MA, Callejas S, Dopazo A, Irizarry RA: Processing of Agilent microRNA array data. BMC Res Notes 2010, 3:18. BioMed Central Full Text
• [29]Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98(9):5116-5121.
• [30]Smyth GK, Speed TP: Normalization of cDNA microarray data. Methods 2003, 31:265-273.
• [31]Ghaleb AM, Yang VW: The Pathobiology of Kruppel-like Factors in Colorectal Cancer. Curr Colorectal Cancer Rep 2008, 4(2):59-64.
• [32]Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG: The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004, 64(3):883-888.
• [33]Qi J, Zhu YQ, Luo J, Tao WH: Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006, 12(44):7113-7117.
• [34]Yamada M, Ohnishi J, Ohkawara B, Iemura S, Satoh K, Hyodo-Miura J, Kawachi K, Natsume T, Shibuya H: NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J Biol Chem 2006, 281(30):20749-20760.
• [35]da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
• [36]Caldwell GM, Jones CE, Taniere P, Warrack R, Soon Y, Matthews GM, Morton DG: The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas. Br J Cancer 2006, 94(6):922-927.
• [37]Huang D, Yu B, Deng Y, Sheng W, Peng Z, Qin W, Du X: SFRP4 was overexpressed in colorectal carcinoma. J Cancer Res Clin Oncol 2010, 136(3):395-401.
• [38]MacDonald BT, Tamai K, He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17(1):9-26.
• [39]Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA: Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E et al: The colorectal microRNAome. Proc Natl Acad Sci U S A 2006, 103(10):3687-3692.
• [40]Wang X, Wang J, Ma H, Zhang J, Zhou X: Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 2011, 29(2):919-27.
• [41]Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al.: EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 2010, 70(21):8822-8831.
• [42]Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW: Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A 2008, 105(35):13021-13026.
• [43]Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et al.: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008, 68(10):3566-3572.
• [44]Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ: Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 2009, 284(9):5731-5741.
• [45]Sugimura R, Li L: Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today 2010, 90(4):243-256.
• [46]Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14(15):1837-1851.